SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form CERT - Certification by an exchange approving securities for listing:
SEC Accession No. 0001354457-19-000553
Filing Date
2019-10-28
Accepted
2019-10-28 16:07:56
Documents
1
Effectiveness Date
2019-10-28

Document Format Files

Seq Description Document Type Size
1 8A CERT 8A_Cert_OYST.pdf CERT 62217
  Complete submission text file 0001354457-19-000553.txt   86877
Mailing Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540
Business Address 202 CARNEGIE CENTER SUITE 109 PRINCETON NJ 08540 (609) 382-9032
Oyster Point Pharma, Inc. (Filer) CIK: 0001720725 (see all company filings)

IRS No.: 811030955 | State of Incorp.: DE | Fiscal Year End: 1231
Type: CERT | Act: 34 | File No.: 001-39112 | Film No.: 191173106
SIC: 2836 Biological Products, (No Diagnostic Substances)